Biocidal products

Draft Commission Implementing Decision on the non-approval of 1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH) as an existing active substance for use in biocidal products of product types 6 and 13in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council; (4 page(s), in English)

This draft Commission Implementing Decision does not approve 1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione (DMDMH) as an existing active substance for use in biocidal products of product types 6 and 13.

This active substance cannot be approved because no sufficient efficacy was demonstrated for any use. In addition, for the environment, no safe use could be identified. As a consequence, articles treated with or incorporating this active substance may not be placed on the market in the Union 180 days after a decision on the non-approval.